AVCR Fundamental Analysis - AVRICORE HEALTH INC

Name: AVRICORE HEALTH INC (AVCR) Stock
Brand: AVRICORE HEALTH INC
Rating: 1 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to AVCR. AVCR was compared to 9 industry peers in the Health Care Technology industry. AVCR has a great financial health rating, but its profitability evaluates not so good. AVCR is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

AVCR had negative earnings in the past year.

AVCR had a positive operating cash flow in the past year.

AVCR had negative earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: AVCR reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -85.63%, AVCR is doing worse than 66.67% of the companies in the same industry.

AVCR's Return On Equity of -88.09% is in line compared to the rest of the industry. AVCR outperforms 55.56% of its industry peers.

		Industry Rank	Sector Rank
ROA	-85.63%
ROE	-88.09%
ROIC	N/A

ROA(3y)-29.53%

ROA(5y)-86.04%

ROE(3y)-36.85%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AVCR's Gross Margin of 42.97% is in line compared to the rest of the industry. AVCR outperforms 55.56% of its industry peers.

AVCR's Gross Margin has declined in the last couple of years.

AVCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	42.97%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.52%

GM growth 5Y-2.21%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for AVCR has been increased compared to 1 year ago.

The number of shares outstanding for AVCR has been increased compared to 5 years ago.

There is no outstanding debt for AVCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

AVCR has an Altman-Z score of 51.41. This indicates that AVCR is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 51.41, AVCR belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.

AVCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	51.41

ROIC/WACCN/A

WACC9.01%

2.3 Liquidity

AVCR has a Current Ratio of 20.42. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 20.42, AVCR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

A Quick Ratio of 20.31 indicates that AVCR has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 20.31, AVCR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	20.42
Quick Ratio	20.31

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AVCR have decreased strongly by -15200.00% in the last year.

AVCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.23%.

AVCR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 170.57% yearly.

EPS 1Y (TTM)-15200%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1000%

Revenue 1Y (TTM)-31.23%

Revenue growth 3Y239.04%

Revenue growth 5Y170.57%

Sales Q2Q%-97.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVCR. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than AVCR, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	24.17
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AVCR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AVRICORE HEALTH INC

TSX-V:AVCR (10/30/2025, 7:00:00 PM)

0.055

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)08-27 2025-08-27

Earnings (Next)11-27 2025-11-27

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners7.94%

Ins Owner ChangeN/A

Market Cap5.57M

Revenue(TTM)3.08M

Net Income(TTM)-1427900

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.81
P/FCF	24.17
P/OCF	13.95
P/B	3.44
P/tB	3.6
EV/EBITDA	N/A

EPS(TTM)-0.02

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFY4.14%

OCF(TTM)0

OCFY7.17%

SpS0.03

BVpS0.02

TBVpS0.02

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-85.63%
ROE	-88.09%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	42.97%
FCFM	7.49%

ROA(3y)-29.53%

ROA(5y)-86.04%

ROE(3y)-36.85%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.52%

GM growth 5Y-2.21%

F-Score6

Asset Turnover1.85

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	N/A
Cap/Depr	53.31%
Cap/Sales	5.49%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	20.42
Quick Ratio	20.31
Altman-Z	51.41

F-Score6

WACC9.01%

ROIC/WACCN/A

Cap/Depr(3y)316.46%

Cap/Depr(5y)N/A

Cap/Sales(3y)34.03%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-15200%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1000%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-31.23%

Revenue growth 3Y239.04%

Revenue growth 5Y170.57%

Sales Q2Q%-97.25%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-19693.8%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y118.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y78.74%

OCF growth 3YN/A

OCF growth 5YN/A

AVRICORE HEALTH INC / AVCR.CA FAQ

What is the fundamental rating for AVCR stock?

ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA.

What is the valuation status for AVCR stock?

ChartMill assigns a valuation rating of 2 / 10 to AVRICORE HEALTH INC (AVCR.CA). This can be considered as Overvalued.

Can you provide the profitability details for AVRICORE HEALTH INC?

AVRICORE HEALTH INC (AVCR.CA) has a profitability rating of 1 / 10.

Can you provide the financial health for AVCR stock?

The financial health rating of AVRICORE HEALTH INC (AVCR.CA) is 8 / 10.

AVRICORE HEALTH INC (AVCR.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AVRICORE HEALTH INC / AVCR.CA FAQ

What is the fundamental rating for AVCR stock?

What is the valuation status for AVCR stock?

Can you provide the profitability details for AVRICORE HEALTH INC?

Can you provide the financial health for AVCR stock?